Bactericidal activity of N-chlorotaurine against biofilm-forming bacteria grown on metal disks

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 4, 2014, Pages 2235-2239

  Coraça Huber, Débora C ^a   Ammann, Christoph G ^a   Fille, Manfred ^a   Hausdorfer, Johann ^a   Nogler, Michael ^a   Nagl, Markus ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORHEXIDINE; CHLORINE DERIVATIVE; MICROBICIDE; N CHLOROTAURINE; POLYSTYRENE; TAURINE DERIVATIVE; TITANIUM; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GROWTH; BACTERIAL METABOLISM; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; BIOFILM; COLONY FORMING UNIT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG TOLERANCE; EXTRACELLULAR MATRIX; IN VITRO STUDY; METABOLIC INHIBITION; METAL IMPLANTATION; ORTHOPEDIC SURGERY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SCANNING ELECTRON MICROSCOPY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; XTT ASSAY;

ANTI-BACTERIAL AGENTS; BIOFILMS; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; TAURINE;

EID: 84896990322     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02700-13     Document Type: Article

References (32)

1. Hosman AH, van der Mei HC, Bulstra SK, Busscher HJ, Neut D. 2009. Metal-on-metal bearings in total hip arthroplasties: influence of cobalt and chromium ions on bacterial growth and biofilm formation. J. Biomed. Mater. Res. A 88:711-716. http://dx.doi.org/10.1002/jbm.a.31922.
2. Schommer NN, Christner M, Hentschke M, Ruckdeschel K, Aepfelbacher M, Rohde H. 2011. Staphylococcus epidermidis uses distinct mechanisms of biofilm formation to interfere with phagocytosis and activation of mouse macrophage-like cells 774A. 1. Infect. Immun. 79:2267-2276. http://dx.doi.org/10.1128/IAI. 01142-10.
3. Grisham MB, Jefferson MM, Melton DF, Thomas EL. 1984. Chlorination of endogenous amines by isolated neutrophils. J. Biol. Chem. 259:10404-10413.
4. Gottardi W, Nagl M. 2002. Chemical properties of N-chlorotaurine sodium, a key compound in the human defence system. Arch. Pharm. (Weinheim) 335:411- 421. http://dx.doi.org/10.1002/1521-4184(200212)335:9〈411::AID- ARDP411〉3.0.CO;2-D.
5. Gottardi W, Nagl M. 2010. N-chlorotaurine, a natural antiseptic with outstanding tolerability. J. Antimicrob. Chemother. 65:399-409. http://dx.doi.org/10.1093/jac/dkp466.
6. Kontny E, Chorazy-Massalska M, Rudnicka W, Marcinkiewicz J, Maslinski W. 2007. Comparison of taurine chloramine and taurine bromamine effects on rheumatoid arthritis synoviocytes. Amino Acids 32:447-452. http://dx.doi.org/10. 1007/s00726-006-0368-0. (Pubitemid 46559570)
7. Verdrengh M, Tarkowski A. 2005. Inhibition of septic arthritis by local administration of taurine chloramine, a product of activated neutrophils. J. Rheumatol. 32:1513-1517. (Pubitemid 41113973)
8. Eitzinger C, Ehrlenbach S, Lindner H, Kremser L, Gottardi W, Debabov D, Anderson M, Nagl M, Orth D. 2012. N-chlorotaurine, a long-lived oxidant produced by human leukocytes, inactivates Shiga toxin of enterohemorrhagic Escherichia coli. PLoS One 7:e47105. http://dx.doi.org/10.1371/journal.pone.0047105.
9. Martini C, Hammerer-Lercher A, Zuck M, Jekle A, Debabov D, Anderson M, Nagl M. 2012. Antimicrobial and anticoagulant activity of N-chlorotaurine (NCT), N,N-dichloro-2,2-dimethyltaurine (NVC-422) and N-monochloro-2,2-dimethyltaurine (NVC-612) in human blood. Antimicrob. Agents Chemother. 56:1979-1984. http://dx.doi.org/10.1128/AAC.05685-11.
10. Neher A, Arnitz R, Gstöttner M, Schäfer D, Kröss E, Nagl M. 2008. Antimicrobial activity of dexamethasone and its combination with Nchlorotaurine. Arch. Otolaryngol. Head Neck Surg. 134:615-620. http://dx.doi.org/10.1001/archotol.134.6.615. (Pubitemid 351871021)
11. Marcinkiewicz J, Strus M, Walczewska M, Machul A, Mikolajczyk D. 2013. Influence of taurine haloamines (TauCl and TauBr) on the development of Pseudomonas aeruginosa biofilm: a preliminary study. Adv. Exp. Med. Biol. 775: 269-283. http://dx.doi.org/10.1007/978-1-4614-6130-2-23.
12. Singhal D, Jekle A, Debabov D, Wang L, Khosrovi B, Anderson M, Foreman A, Wormald PJ. 2012. Efficacy of NVC-422 against Staphylococcus aureus biofilms in a sheep biofilm model of sinusitis. Int. Forum Allergy Rhinol. 2:309-315. http://dx.doi.org/10.1002/alr.21038.
13. D'Antonio JA, Capello WN, Manley MT, Geesink R. 2001. Hydroxyapatite femoral stems for total hip arthroplasty: 10- to 13-year follow-up. Clin. Orthop. Relat. Res. 2001(393):101-111. (Pubitemid 33101703)
14. Coraca-Huber DC, Fille M, Hausdorfer J, Pfaller K, Nogler M. 2012. Evaluation of MBEC-HTP biofilm model for studies of implant associated infections. J. Orthop. Res. 30:1176-1180. http://dx.doi.org/10.1002/jor.22065.
15. Costerton JW, Stewart PS, Greenberg EP. 1999. Bacterial biofilms: a common cause of persistent infections. Science 284:1318-1322. http://dx.doi.org/10.1126/science.284.5418.1318. (Pubitemid 29289651)
16. Sugimoto S, Iwamoto T, Takada K, Okuda K, Tajima A, Iwase T, Mizunoe Y. 2013. Staphylococcus epidermidis Esp degrades specific proteins associated with Staphylococcus aureus biofilm formation and host-pathogen interaction. J. Bacteriol. 195:1645-1655. http://dx.doi.org/10.1128/JB.01672-12.
17. Chiang P, Sampaleanu LM, Ayers M, Pahuta M, Howell PL, Burrows LL. 2008. Functional role of conserved residues in the characteristic secretion NTPase motifs of the Pseudomonas aeruginosa type IV pilus motor proteins PilB, PilT and PilU. Microbiology 154:114-126. http://dx.doi.org/10.1099/mic.0.2007/011320-0. (Pubitemid 351201392)
18. Jekle A, Yoon J, Zuck M, Najafi R, Wang L, Shiau T, Francavilla C, Rani SA, Eitzinger C, Nagl M, Anderson M, Debabov D. 2013. NVC-422 inactivates Staphylococcus aureus toxins. Antimicrob. Agents Chemother. 57:924-929. http://dx.doi.org/10.1128/AAC.01945-12.
19. Marcinkiewicz J, Kontny E. 2014. Taurine and inflammatory diseases. Amino Acids 46:7-20. http://dx.doi.org/10.1007/s00726-012-1361-4.
20. Gottardi W, Nagl M. 2013. Active halogen compounds and proteinaceous material: loss of activity of topical anti-infectives by halogen consumption. J. Pharm. Pharmacol. 65:213-218. http://dx.doi.org/10.1111/j.2042-7158.2012.01589. x.
21. Gottardi W, Debabov D, Nagl M. 2013. N-chloramines: a promising class of well-tolerated topical anti-infectives. Antimicrob. Agents Chemother. 57:1107-1114. http://dx.doi.org/10.1128/AAC.02132-12.
22. Nagl M, Nguyen VA, Gottardi W, Ulmer H, Höpfl R. 2003. Tolerability and efficacy of N-chlorotaurine compared to chloramine T for treatment of chronic leg ulcers with purulent coating. Br. J. Dermatol. 149:590-597. http://dx.doi.org/10.1046/j.1365-2133.2003.05432.x. (Pubitemid 37281593)
23. Neher A, Nagl M, Appenroth E, Gstöttner M, Wischatta M, Reisigl F, Schindler M, Ulmer H, Stephan K. 2004. Acute otitis externa: efficacy and tolerability of N-chlorotaurine, a novel endogenous antiseptic agent. Laryngoscope 114:850-854. http://dx.doi.org/10.1097/00005537-200405000-00011. (Pubitemid 38625535)
24. Presterl E, Suchomel M, Eder M, Reichmann S, Lassnigg A, Graninger W, Rotter M. 2007. Effects of alcohols, povidone-iodine and hydrogen peroxide on biofilms of Staphylococcus epidermidis. J. Antimicrob. Chemother. 60:417-420. http://dx.doi.org/10.1093/jac/dkm221. (Pubitemid 47243897)
25. McDonnell G, Russell AD. 1999. Antiseptics and disinfectants: activity, action, and resistance. Clin. Microbiol. Rev. 12:147-179. (Pubitemid 29055958)
26. Bonez PC, Dos Santos Alves CF, Dalmolin TV, Agertt VA, Mizdal CR, Flores VD, Marques JB, Santos RC, Anraku de Campos MM. 2013. Chlorhexidine activity against bacterial biofilms. Am. J. Infect. Control. 41(12):e119-22. http://dx.doi.org/10.1016/j.ajic.2013.05.002.
27. Frater M, Braunitzer G, Urban E, Bereczki L, Antal M, Nagy K. 2013. In vitro efficacy of different irrigating solutions against polymicrobial human root canal bacterial biofilms. Acta Microbiol. Immunol. Hung. 60:187-199. http://dx.doi.org/10.1556/AMicr.60.2013.2.9.
28. Wood TK, Knabel SJ, Kwan BW. 2013. Bacterial persister cell formation and dormancy. Appl. Environ. Microbiol. 79:7116-7121. http://dx.doi.org/10.1128/ AEM.02636-13.
29. Nagl M, Pfausler B, Schmutzhard E, Fille M, Gottardi W. 1998. Tolerance and bactericidal action of N-chlorotaurine in a urinary tract infection by an omniresistant Pseudomonas aeruginosa. Zentralbl. Bakteriol. 288:217-223. http://dx.doi.org/10.1016/S0934-8840(98)80043-1. (Pubitemid 28503916)
30. Nagl M, Hengster P, Semenitz E, Gottardi W. 1999. The postantibiotic effect of N-chlorotaurine on Staphylococcus aureus. Application in the mouse peritonitis model. J. Antimicrob. Chemother. 43:805-809. (Pubitemid 29273730)
31. Kwasny-Krochin B, Bobek M, Kontny E, Gluszko P, Biedron R, Chain BM, Maslinski W, Marcinkiewicz J. 2002. Effect of taurine chloramine, the product of activated neutrophils, on the development of collagen-induced arthritis in DBA 1/J. mice. Amino Acids 23:419-426. http://dx.doi.org/10.1007/s00726-002-0207-x. (Pubitemid 35435601)
32. Wang Y, Cha YN, Kim KS, Kim C. 2011. Taurine chloramine inhibits osteoclastogenesis and splenic lymphocyte proliferation in mice with collagen-induced arthritis. Eur. J. Pharmacol. 668:325-330. http://dx.doi.org/ 10.1016/j.ejphar.2011.07.017.